Key result
Troponin I and CK-MB confirm AMI faster than troponin T, with troponin I showing highest specificity.
Why the study?
An improved microplate immunoassay procedure for measuring troponin T and an immunoassay for troponin I were developed to compare their diagnostic performance for acute myocardial infarction.
Do troponin T and troponin I ELISA tests improve the diagnosis of acute myocardial infarction compared to creatine kinase MB mass?
Observational (n=203)
No
Do troponin T and troponin I ELISA tests improve the diagnosis of acute myocardial infarction compared to creatine kinase MB mass?
p-value: p=0.043
Troponin I demonstrates superior early sensitivity and cardiac specificity compared to troponin T for the diagnosis of acute myocardial infarction.
May support troponin I for rapid AMI confirmation; leaves open larger prospective validation before practice change.
We describe an improved procedure using a standard microplate immunoassay reader to measure the concentration of troponin T in human serum. We also describe an immunoassay for troponin I in serum. Only 160 microliters of serum are needed for a single analysis of each troponin. For comparison, creatine kinase MB mass analysis in serum was performed with a commercial luminometric method. From 95 apparently healthy people the following values were obtained: creatine kinase MB mass 2.6 +/- 1.2 micrograms/l, troponin T 0.027 +/- 0.025 microgram/l and troponin I 0.03 +/- 0.031 microgram/l. We compared the results of troponin T and troponin I methods with each other, as well as with those of creatine kinase MB mass measured in 48 patients with verified acute myocardial infarction and in 60 control patients with non-cardiac chest pain. The correlation between troponin T and troponin I values was 0.91 for the total material and 0.94 for 48 patients with acute myocardial infarction. Troponin I showed better earlier sensitivity than troponin T (p = 0.043). In nine patients in the control group, creatine kinase MB mass exceeded the reference limit of 5.0 micrograms/l, while in two patients the cut-off limit of 10.0 micrograms/l was also surpassed, pointing to non-specificity. In the group of infarct patients, the highest serum creatinine value was 193 mumol/l, whereas in the control group it was 406 mumol/l. The sera of patients with impaired renal function without any cardiac failure showed no increase in troponin T and troponin I values. In conclusion, serum creatine kinase MB mass and troponin I seem to confirm an acute myocardial infarction more rapidly than does troponin T; troponin I has the highest cardiac specificity.
No takes yet. Share an insight, caveat, or question.
Penttilä et al. (1997) conducted an observational in Acute Myocardial Infarction (n=203). Troponin I and Troponin T ELISA tests vs. Creatine kinase MB mass was evaluated on Earlier sensitivity (rate of increase) for acute myocardial infarction (p=0.043). Serum troponin I and creatine kinase MB mass confirmed acute myocardial infarction more rapidly than troponin T (p=0.043), with troponin I demonstrating the highest cardiac specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: